Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Tripepi

Showing results (31-40 of 516) with videos related to

Pageof 52
Sort By:
International Journal of Environmental Research and Public Health|November 3, 2020
Sleep Health Promotion in the WorkplaceSergio Garbarino, Giovanni Tripepi, Nicola Magnavita
Kidney International. Supplement|May 20, 2003
Traditional and emerging cardiovascular risk factors in end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Kidney International. Supplement|April 16, 2003
Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Journal of the American Society of Nephrology : JASN|June 7, 2005
Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modelingGiovanni Tripepi, Francesca Mallamaci, Carmine Zoccali
Journal of the American Society of Nephrology : JASN|December 20, 2003
Novel cardiovascular risk factors in end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 23, 2011
[Linear regression analysis in clinical research]Fabio Provenzano, Carmine Zoccali, Giovanni Tripepi
Seminars in Dialysis|November 10, 2007
It is important to lower homocysteine in dialysis patientsCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Seminars in Nephrology|November 22, 2005
Predictors of cardiovascular death in ESRDCarmine Zoccali, Giovanni Tripepi, Francesca Mallamaci
Seminars in Dialysis|September 28, 2007
Cardiovascular risk profile assessment and medication control should come firstCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Journal of the American Society of Nephrology : JASN|November 30, 2006
Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?Carmine Zoccali, Giovanni Tripepi, Francesca Mallamaci
Pageof 52

Showing results (31-40 of 516) with videos related to

Sort By:
Pageof 52
International Journal of Environmental Research and Public Health|November 3, 2020
Sleep Health Promotion in the WorkplaceSergio Garbarino, Giovanni Tripepi, Nicola Magnavita
Kidney International. Supplement|May 20, 2003
Traditional and emerging cardiovascular risk factors in end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Kidney International. Supplement|April 16, 2003
Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Journal of the American Society of Nephrology : JASN|June 7, 2005
Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modelingGiovanni Tripepi, Francesca Mallamaci, Carmine Zoccali
Journal of the American Society of Nephrology : JASN|December 20, 2003
Novel cardiovascular risk factors in end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 23, 2011
[Linear regression analysis in clinical research]Fabio Provenzano, Carmine Zoccali, Giovanni Tripepi
Seminars in Dialysis|November 10, 2007
It is important to lower homocysteine in dialysis patientsCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Seminars in Nephrology|November 22, 2005
Predictors of cardiovascular death in ESRDCarmine Zoccali, Giovanni Tripepi, Francesca Mallamaci
Seminars in Dialysis|September 28, 2007
Cardiovascular risk profile assessment and medication control should come firstCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi
Journal of the American Society of Nephrology : JASN|November 30, 2006
Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?Carmine Zoccali, Giovanni Tripepi, Francesca Mallamaci
Pageof 52